LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 48 filers reported holding LOGICBIO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,000 | -98.8% | 12,298 | -97.6% | 0.00% | – |
| Q1 2022 | $346,000 | -70.6% | 508,190 | -0.1% | 0.00% | – |
| Q4 2021 | $1,175,000 | +508.8% | 508,475 | +1105.3% | 0.00% | – |
| Q3 2021 | $193,000 | -20.9% | 42,186 | -23.3% | 0.00% | – |
| Q2 2021 | $244,000 | -3.2% | 55,030 | +59.0% | 0.00% | – |
| Q1 2021 | $252,000 | +9.1% | 34,607 | +14.3% | 0.00% | – |
| Q4 2020 | $231,000 | -13.2% | 30,290 | +3.3% | 0.00% | – |
| Q3 2020 | $266,000 | -20.6% | 29,314 | -26.0% | 0.00% | – |
| Q2 2020 | $335,000 | +159.7% | 39,637 | +52.0% | 0.00% | – |
| Q1 2020 | $129,000 | -28.7% | 26,070 | +3.6% | 0.00% | – |
| Q4 2019 | $181,000 | -29.3% | 25,172 | +6.2% | 0.00% | – |
| Q3 2019 | $256,000 | -62.1% | 23,692 | -63.5% | 0.00% | – |
| Q4 2018 | $675,000 | – | 64,949 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 500,000 | $2,470,000 | 0.65% |
| Orbimed Advisors | 6,466,783 | $31,946,000 | 0.54% |
| SAMLYN CAPITAL, LLC | 798,566 | $3,945,000 | 0.10% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 915,355 | $4,522,000 | 0.01% |
| IHT Wealth Management, LLC | 11,660 | $58,000 | 0.01% |
| FIDUCIARY TRUST CO | 37,998 | $188,000 | 0.01% |
| FRANKLIN RESOURCES INC | 700,000 | $3,458,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 13,700 | $68,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 2,249 | $11,000 | 0.00% |
| MANCHESTER FINANCIAL INC | 200 | $1,000 | 0.00% |